![Jacquelyn Sumer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacquelyn Sumer
Compliance Officer chez
CULLINAN THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Ms. Jacquelyn Sumer is a Secretary, Chief Legal & Compliance Officer at Cullinan Therapeutics, Inc. Ms. Sumer was previously employed as a Chief Legal & Compliance Officer by Genocea Biosciences, Inc., a Vice President & Assistant General Counsel by Bristol Myers Squibb Co., and an Executive Director & Senior Corporate Counsel by Celgene Corp.
She received her undergraduate degree from Bucknell University and a graduate degree from Duke University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/02/2026 | 128 089 ( 0,21% ) | 2 M $ | 31/05/2026 |
Postes actifs de Jacquelyn Sumer
| Sociétés | Poste | Début |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Compliance Officer | 15/08/2022 |
Anciens postes connus de Jacquelyn Sumer
| Sociétés | Poste | Fin |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Compliance Officer | 01/06/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/02/2021 |
| CELGENE | Directeur/Membre du Conseil | 01/11/2019 |
Formation de Jacquelyn Sumer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Law
 Duke University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
